The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
Open accessAbstract
Biofilms, likely the predominant mode of device-related microbial infection, exhibit resistance to antimicrobial agents. Evidence suggests that Candida biofilms have dramatically reduced susceptibility to antifungal drugs. We examined antifungal susceptibilities of Candida albicans and Candida parapsilosis biofilms grown on a bioprosthetic model. In addition to conventional agents, we determined if new antifungal agents (triazoles, amphotericin B lipid formulations, and echinocandins) have activities against Candida biofilms. We also explored effects of preincubation of C. albicans cells with subinhibitory concentrations (sub-MICs) of drugs to see if they could modify subsequent biofilm formation. Finally, we used confocal scanning laser microscopy (CSLM) to image planktonic- and biofilm-exposed blastospores to examine drug effects on cell structure.Candida biofilms were formed on silicone elastomer and quantified by tetrazolium and dry weight (DW) assays. Susceptibility testing of fluconazole, nystatin, chlorhexidine, terbenafine, amphotericin B (AMB), and the triazoles voriconazole (VRC) and ravuconazole revealed resistance in all Candida isolates examined when grown as biofilms, compared to planktonic forms. In contrast, lipid formulations of AMB (liposomal AMB and AMB lipid complex [ABLC]) and echinocandins (caspofungin [Casp] and micafungin) showed activity against Candida biofilms. Preincubation of C. albicans cells with sub-MIC levels of antifungals decreased the ability of cells to subsequently form biofilm (measured by DW;P< 0.0005). CSLM analysis of planktonic and biofilm-associated blastospores showed treatment with VRC, Casp, and ABLC resulted in morphological alterations, which differed with each agent. In conclusion, our data show that Candida biofilms show unique susceptibilities to echinocandins and AMB lipid formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“Biofilm drug resistance is a phenomenon consistently expressed across model microbial systems (6, 13, 14, 21, 29) and likely to be of great clinical relevance (16).”
BackgroundMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Microbial Biofilms: from Ecology to Molecular Genetics
Davey, M. E., & O'toole, G. A. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.847-867.2000 · Cited by 3,086
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Self-citationGuidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Gene expression in Pseudomonas aeruginosa biofilms
Whiteley, M., Bangera, M. G., Bumgarner, R. E., Parsek, M. R., Teitzel, G. M., Lory, S., & Greenberg, E. P. (2001) · Nature · doi:10.1038/35101627 · Cited by 1,183
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Self-citationBiofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599
Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro
Chandra, J., Mukherjee, P. K., Leidich, S. D., Faddoul, F. F., Hoyer, L. L., Douglas, L. J., & Ghannoum, M. A. (2001) · Journal of Dental Research · doi:10.1177/00220345010800031101 · Cited by 597
Self-citationRisk factors for candidemia in Neonatal Intensive Care Unit patients
SAIMAN, L., LUDINGTON, E., PFALLER, M., RANGEL-FRAUSTO, S., WIBLIN, T. R., DAWSON, J., BLUMBERG, H. M., PATTERSON, J. E., RINALDI, M., EDWARDS, J. E., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00011 · Cited by 587
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces
Kuhn, D. M., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.878-888.2002 · Cited by 485
Self-citationAntifungal Susceptibility Testing: Practical Aspects and Current Challenges
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., et al. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.643-658.2001 · Cited by 444
Self-citationResistance of Candida albicans biofilms to antifungal agents in vitro
Hawser, S. P., & Douglas, L. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2128 · Cited by 406
Baillie, G. S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.397 · Cited by 389
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378
Sauer, K., & Camper, A. K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.22.6579-6589.2001 · Cited by 377
Nguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363 · cited 2×
“Antifungal therapy alone is insufficient for cure; affected devices generally need to be removed (34, 36, 37, 47).”
BackgroundPredictors of Adverse Outcome in Cancer Patients with Candidemia
Anaissie, E. J., Rex, J. H., Uzun, Ö., & Vartivarian, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00030-8 · Cited by 295
Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A. F., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241
The biofilm glycocalyx as a resistance factor
HOYLE, B. D., JASS, J., & COSTERTON, J. W. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/26.1.1 · Cited by 218
Detection of amphotericin B-resistant Candida isolates in a broth-based system
Rex, J. H., Cooper, C. R., Merz, W. G., Galgiani, J. N., & Anaissie, E. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.906 · Cited by 198
Current and future antifungal therapy: new targets for antifungal agents
Andriole, V. T. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.151 · Cited by 190
Permeation of Antimicrobial Agents through Pseudomonas aeruginosa Biofilms: A Simple Method
Shigeta, M., Tanaka, G., Komatsuzawa, H., Sugai, M., Suginaka, H., & Usui, T. (1997) · Chemotherapy · doi:10.1159/000239587 · Cited by 187
Weems, J. J., Chamberland, M. E., Ward, J., Willy, M., Padhye, A. A., & Solomon, S. L. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.6.1029-1032.1987 · Cited by 181
Surface-induced and biofilm-induced changes in gene expression
Kuchma, S. L., & O’Toole, G. A. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00123-3 · Cited by 181
Risk factors for death in patients with candidemia
Nucci, M., Colombo, A. L., Silveira, F., Richtmann, R., Salomão, R., Branchini, M. L., & Spector, N. (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647743 · Cited by 178
Rex, J. H., Nelson, P. W., Paetznick, V. L., Lozano-Chiu, M., Espinel-Ingroff, A., & Anaissie, E. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.129 · Cited by 167
[48] Candida biofilms and their susceptibility to antifungal agents
Baillie, G. S., & Douglas, L. J. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)10050-8 · Cited by 161
Arthington-Skaggs, B. A., Warnock, D. W., & Morrison, C. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2081-2085.2000 · Cited by 142 · cited 1×
“However, apparent viable cells may represent a trailing phenomenon, which may not be of clinical relevance (5, 44).”
BackgroundHawser, S., Norris, H. A., Jessup, C. J., & Ghannoum, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1450-1452.1998 · Cited by 140
Self-citationKurtz, M., Abruzzo, G. K., Flattery, A. M., Bartizal, K. F., Marrinan, J. A., Li, W., Milligan, J. A., Nollstadt, K. H., & Douglas, C. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3244-3251.1996 · Cited by 136
Nosocomial acquisition of Candida parapsilosis: An epidemiologic study
Sánchez, V., Vázquez, J. A., Barth-Jones, D. C., Dembry, L. M., Sobel, J. D., & Zervos, M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90207-6 · Cited by 133
Johnson, E. M., Ojwang, J. O., Székely, A., Wallace, T. L., & Warnock, D. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1412 · Cited by 118
Vázquez, J. A., Lynch, M., Boikov, D. A., & Sobel, J. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1612 · Cited by 118
Marco, F., Pfaller, M. A., Messer, S. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00050-9 · Cited by 107
Pagano, L., Antinori, A., Ammassari, A., Mele, L., Nosari, A., Melillo, L. M. A., Martino, B., Sanguinetti, M., Equitani, F., Nobile, F., et al. (1999) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1999.tb01120.x · Cited by 97
van Etten, E. W. M., Otte-Lambillion, M., van Vianen, W., ten Kate, M. T., & Bakker‐Woudenberg, I. A. J. M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.4.509 · Cited by 86
Barchiesi, F., Schimizzi, A. M., Fothergill, A. W., Scalise, G., & Rinaldi, M. G. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00015011 · Cited by 74
Use of antibiotic locks to treat colonized central venous catheters
Berrington, A. W., & Gould, F. K. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.5.597 · Cited by 67
Tresse, O., Jouenne, T., & Junter, G. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.3.521 · Cited by 66
Belanger, P. H., Nast, C. C., Fratti, R. A., Sanati, H., & Ghannoum, M. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1840 · Cited by 64
Self-citationBekersky, I., Boswell, G. W., Hiles, R., Fielding, R. M., Buell, D. N., & Walsh, T. J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007605024942 · Cited by 63
Pfaller, M. A., Messer, S. A., Mills, K., Bolmström, A., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4387-4389.2001 · Cited by 63
Cuenca‐Estrella, M., Mellado, E., Díaz-Guerra, T. M., Monzón, A., & Rodríguez-Tudela, J. L. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.475 · Cited by 63
Krčméry, V., & Kovacicova, G. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00096-6 · Cited by 56
Chapin-Robertson, K., Dahlberg, S. E., & Edberg, S. C. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.2.377-380.1992 · Cited by 54
Ghannoum, M. A., Filler, S. G., Ibrahim, A. S., Fu, Y., & Edwards, J. E. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2239 · Cited by 50
Self-citationBarchiesi, F., Schimizzi, A. M., Fothergill, A. W., Scalise, G., & Rinaldi, M. G. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050283 · Cited by 43
Nosocomial candidaemias due to species other than Candida albicans in cancer patients
Krcmery, V., Mrázová, M., Kunova, A., Grey, E., Mardiak, J., Jurga, L., Sabo, A., Šufliarský, J., Ševčíková, L., Sorkovská, D., et al. (1999) · Supportive Care in Cancer · doi:10.1007/s005200050304 · Cited by 32
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184
Metadata
- Authors
- Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-06
- Volume
- 46
- Issue
- 6
- Pages
- 1773-1780
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2087712604
- Cited by
- 764
- References
- 57
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.